Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed August 9, 2026.
International Agency for Research on Cancer (IARC) is a company within the Health category. The International Agency for Research on Cancer (IARC) is an intergovernmental agency forming part of the World Health Organization of the United Nations. It conducts and coordinates research into the causes of cancer, and its program, IARC Monographs, evaluates and classifies agents based on their carcinogenicity to humans.
International Agency for Research on Cancer (IARC) is rated Emerging on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for International Agency for Research on Cancer (IARC) is Strong.
AI models classify International Agency for Research on Cancer (IARC) as a Incumbent. AI names brand first.
International Agency for Research on Cancer (IARC) appeared in 3 of 3 sampled buyer-intent queries (100%). The core information about IARC's classifications, publications, and methodology is highly discoverable through clear navigation and direct content links within the provided context. There are no significant gaps for users seeking specific information about the IARC Monographs program.
IARC is perceived as a leading international authority in the field of cancer research and the classification of carcinogenic agents. Its Monographs program provides rigorously evaluated scientific classifications that are widely respected and utilized globally for public health policy and research. The organization emphasizes transparency, scientific detail, and responsible communication regarding its findings. Key gap: None observed. The information is consistently presented and factual.
Of 4 key facts verified about International Agency for Research on Cancer (IARC), 4 are well-documented (likely accurate across AI models), 0 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
A key vulnerability is the potential for misinterpretation or oversimplification of complex scientific classifications by the general public or media if the full context and detailed monographs are not consulted. The organization explicitly warns against this in its own text, highlighting the importance of understanding the nuances of scientific evidence.
Buyers turn to International Agency for Research on Cancer (IARC) for Ad-hoc Expert Panels: Instead of a continuous, structured program like the IARC Monographs, reliance on disparate, one-off expert panels for carcinogenicity assessments, leading to potential inconsist, Individual Academic Research: Each research institution or individual scientist conducting their own assessments of chemical safety and carcinogenicity without a central, authoritative body to synthes, Absence of Centralized Classification: Without an organization like IARC, there would be no internationally recognized, harmonized classification system for carcinogenic agents, impeding global public, among 3 documented problem areas.
Buyers evaluating International Agency for Research on Cancer (IARC) typically ask AI models about "IARC carcinogen classification list", "What is IARC Group 1?", "IARC monographs publications".
International Agency for Research on Cancer (IARC)'s core products are Scientific evaluations and classifications of carcinogenic agents (IARC Monographs), comprehensive publications, and public health guidance related to cancer prevention..
International Agency for Research on Cancer (IARC) uses Information and many publications are freely accessible online. The organization accepts donations..
International Agency for Research on Cancer (IARC) serves Scientists, public health professionals, policymakers, regulatory bodies, medical researchers, and the general public interested in cancer causes and prevention..
International Agency for Research on Cancer (IARC) Global authority in independent scientific evaluation and classification of carcinogens, providing a harmonized international standard for hazard identification, backed by the World Health Organization. Emphasizes scientific rigor and transparency.
Brand Authority Index (BAI) tier: Emerging (exact score locked for unclaimed brands)
Archetype: Incumbent
Official website: https://monographs.iarc.who.int/
Last analyzed: August 9, 2026
This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile